Industry News Facilities & Equipment Future of Pharma Interviews Business & Trends Technology & Manufacturing

Sustainability Is the New Survival Strategy

Green issues shouldn’t be treated as “woke.” Instead, they should be seen as pharma’s license to operate. Three industry experts discuss.

01/21/2026 10 min read Interview

Cell & Gene Industry News Research News

This Week’s CGT News: Bristol Myers Ends Cellares Manufacturing Agreement

August 31, 2026

4 min read

A first-in-human study reduces stem-cell collection and manufacturing times, Bristol Myers ends its Breyanzi agreement with Cellares, and two approaches strengthen CAR T-cell activity against solid tumors

Development & Clinical Small Molecules Interviews

Musings from The Power List: Christine Allen

August 28, 2026

2 min read

Christine Allen believes AI will connect every stage of drug development, but only if it remains guided by human expertise

Biopharma Industry News Development & Clinical

Phase III Success Marks Milestone for Personalized Cancer Vaccines

August 26, 2026

7 min read

Merck and Moderna report positive phase III results for intismeran in melanoma, as The Medicine Maker revisits how cancer vaccines work and the challenges still facing the field

Biopharma Interviews Business & Trends

Green Shoots, Gray Skies

August 26, 2026

9 min read

Jon Rees sees signs of recovery following biotech's post-pandemic funding reset, but there’s no going back to the “old normal”

Explore

Featured Topics

Issues

Topics

News & Blogs

Community & Awards

Sustainability Is the New Survival Strategy

Recommended

Related Content

This Week’s CGT News: Bristol Myers Ends Cellares Manufacturing Agreement

Musings from The Power List: Christine Allen

Phase III Success Marks Milestone for Personalized Cancer Vaccines

Green Shoots, Gray Skies